Product Information

CARBAMAZEPINE 100 MG/5 ML SUSP is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0960 per ML under NDC 51672404704. Its NADAC has been published 43 times since Oct 29, 2025.

FDA first approved this application on Sep 20, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE 100 MG/5 ML SUSP

Carbamazepine
$0.0960per ML

Strength

100 mg/5mL

NDC

51672404704

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA076729

FDA Approved

9/20/2004

TE Code

AB

On Market Since

9/20/2004

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has been published 43 times since Oct 29, 2025, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0960 per ML
All-time high$0.1134 (Dec 10, 2025)
All-time low$0.0955 (Jul 22, 2026)
52-week high$0.1134
52-week low$0.0955
Median price$0.1039
Average price$0.1046
Largest weekly change-4.7% (Feb 18, 2026)
Weeks tracked43
Tracking sinceOct 29, 2025

Price History

1W

+0.5%

1M

+0.5%

3M

-4.6%

6M

-8.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-14.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE 100 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 100 MG/5 ML SUSP, manufactured by Sun Pharmaceutical Industries Inc., is $0.0960 per ML (NDC 51672404704), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE 100 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has declined 14.1%. It has been tracked across 43 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 100 MG/5 ML SUSP?

Since Oct 29, 2025, the NADAC for CARBAMAZEPINE 100 MG/5 ML SUSP has ranged from a low of $0.0955 (Jul 22, 2026) to a high of $0.1134 (Dec 10, 2025), with a median of $0.1039 per ML.

Are there cheaper alternatives to CARBAMAZEPINE 100 MG/5 ML SUSP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARBAMAZEPINE 100 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures CARBAMAZEPINE 100 MG/5 ML SUSP?

CARBAMAZEPINE 100 MG/5 ML SUSP (NDC 51672404704) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.